繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
立即開戶
UnitedHealth | 10-Q: Q3 2024 Earnings Report
UnitedHealth | 10-Q: Q3 2024 Earnings Report
聯合健康 | 10-Q:2024財年三季報
牛牛AI助理已提取核心訊息
UnitedHealth Group Incorporated reported a 9% increase in consolidated revenues to $100.82 billion for the third quarter of 2024, compared to $92.36 billion in the same period last year. The revenue growth was primarily driven by the company's Optum Rx and Optum Health segments, as well as growth across UnitedHealthcare's domestic offerings. Earnings from operations rose slightly to $8.7 billion from $8.5 billion year-over-year. However, net earnings attributable to UnitedHealth Group common shareholders saw a 4% increase to $6.055 billion, with diluted earnings per share at $6.51. The company served 2.0 million more people domestically, mainly due to growth in commercial offerings, despite the impact of Medicaid redeterminations. UnitedHealthcare's revenues increased by 7% to $74.85 billion, while Optum's revenues grew by 13% to $63.92 billion. The medical care...Show More
UnitedHealth Group Incorporated reported a 9% increase in consolidated revenues to $100.82 billion for the third quarter of 2024, compared to $92.36 billion in the same period last year. The revenue growth was primarily driven by the company's Optum Rx and Optum Health segments, as well as growth across UnitedHealthcare's domestic offerings. Earnings from operations rose slightly to $8.7 billion from $8.5 billion year-over-year. However, net earnings attributable to UnitedHealth Group common shareholders saw a 4% increase to $6.055 billion, with diluted earnings per share at $6.51. The company served 2.0 million more people domestically, mainly due to growth in commercial offerings, despite the impact of Medicaid redeterminations. UnitedHealthcare's revenues increased by 7% to $74.85 billion, while Optum's revenues grew by 13% to $63.92 billion. The medical care ratio (MCR) increased to 85.2% from 82.3%, reflecting higher medical costs. The company also faced challenges, including a cyberattack on Change Healthcare, which resulted in direct response costs and business disruption impacts totaling $1.7 billion for the nine months ended September 30, 2024. Looking ahead, UnitedHealth Group expects to continue incurring costs related to the cyberattack and is working to restore transaction volumes to pre-event levels. The company remains focused on balancing growth and profitability, managing medical costs, and adapting to regulatory changes.
聯合健康集團公司報告,在2024年第三季度,綜合營業收入增長了9%,達到了1008.2億美元,相比去年同期的923.6億美元。營業收入增長主要受到公司的Optum Rx和Optum Health業務部門的推動,以及UnitedHealthcare國內業務的增長。營運收入從去年的85億美元略微增長至87億美元。然而,歸屬於聯合健康集團普通股東的淨收益增長了4%,達到了60.55億美元,攤薄每股收益爲6.51美元。該公司在國內爲更多人提供服務,主要是由於商業產品的增長,儘管受到醫療補助重新確定的影響。UnitedHealthcare的營收增長了7%,達到了748.5億美元,而Optum的營收增長了...展開全部
聯合健康集團公司報告,在2024年第三季度,綜合營業收入增長了9%,達到了1008.2億美元,相比去年同期的923.6億美元。營業收入增長主要受到公司的Optum Rx和Optum Health業務部門的推動,以及UnitedHealthcare國內業務的增長。營運收入從去年的85億美元略微增長至87億美元。然而,歸屬於聯合健康集團普通股東的淨收益增長了4%,達到了60.55億美元,攤薄每股收益爲6.51美元。該公司在國內爲更多人提供服務,主要是由於商業產品的增長,儘管受到醫療補助重新確定的影響。UnitedHealthcare的營收增長了7%,達到了748.5億美元,而Optum的營收增長了13%,達到了639.2億美元。醫療保健比率從82.3%上升至85.2%,反映出更高的醫療成本。該公司也面臨着挑戰,包括Change Healthcare的網絡攻擊,這導致了截至2024年9月30日的九個月的直接響應成本和業務中斷影響共計17億美元。展望未來,聯合健康集團預計將繼續承擔與網絡攻擊相關的成本,並努力恢復交易量至事件前水平。公司將繼續專注於平衡增長和盈利能力,管理醫療成本,並適應監管變化。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間